Inicio › Trastorno depresivo mayor › Georgia
Ensayos clínicos de Trastorno depresivo mayor en Georgia
31 estudios sobre Trastorno depresivo mayor buscan participantes en Georgia.
Ciudades en Georgia
Texto oficial del estudio (inglés)
A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
- Psych Atlanta, Marietta
ReclutandoFase 3
Edades de 18 a 85 · Todos los sexos · Actualizado el 13 nov 2026 · NCT06793397A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)
- Seaport Investigator Site, Atlanta
- Seaport Investigator Site, Decatur
ReclutandoFase 2
Edades de 18 a 65 · Todos los sexos · Actualizado el 10 nov 2026 · NCT07065240Regulated Stimulation for Optimized Network Activity and Therapeutic Equilibrium
- Emory Healthcare, Atlanta
Reclutando
Edades de 22 a 85 · Todos los sexos · Actualizado el 9 nov 2026 · NCT07594483A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)
- CenExel - Atlanta Center for Medical Research, Atlanta
- CenExel - iResearch Atlanta, Decatur
- CenExel - iResearch Savannah, Savannah
ReclutandoFase 3
Edades de 18 a 74 · Todos los sexos · Actualizado el 9 nov 2026 · NCT07592689A Study of Brenipatide in Adult Participants With Major Depressive Disorder
- CenExel iResearch, LLC, Decatur
ReclutandoFase 3
Edades de 18 a 75 · Todos los sexos · Actualizado el 4 nov 2026 · NCT07412756Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms
- Agile Clinical Research Trials, LLC, Atlanta
ReclutandoFase 3
Edades de 18 a 74 · Todos los sexos · Actualizado el 3 nov 2026 · NCT06559306A Study to Evaluate the Efficacy and Safety of Esketamine for Reduction of Symptoms of Major Depressive Disorder
- Peachford Hospital-Atlanta Behavioral Research, Atlanta
ReclutandoFase 3
Edades de 12 a 17 · Todos los sexos · Actualizado el 3 nov 2026 · NCT07227454A Study of Brenipatide (LY3537031) in Adult Participants With Major Depressive Disorder
- CenExel iResearch, LLC, Decatur
- AGILE Clinical Research Trials, LLC, Sandy Springs
ReclutandoFase 3
Edades de 18 a 75 · Todos los sexos · Actualizado el 3 nov 2026 · NCT07775300Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder
- The Emory Clinic, Atlanta
- CenExeli Research LLC, Decatur
ReclutandoFase 3
Edades de 18 a 65 · Todos los sexos · Actualizado el 3 nov 2026 · NCT05850689A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder
- Agile Clinical Research Trials, LLC, Atlanta
- Accelerated Clinical Research Group LLC, Snellville
ReclutandoFase 3
Edades de 18 a 74 · Todos los sexos · Actualizado el 3 nov 2026 · NCT07573176Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, Atlanta
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 2 nov 2026 · NCT06966401A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD)
- Clinical Research Site, Norcross
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 30 oct 2026 · NCT07621237Double-blind, Placebo-controlled Study in Adults With Major Depressive Disorder
- Cenexel Atlanta (ACMR), Atlanta
- Cenexel iResearch Atlanta, Decatur
ReclutandoFase 2
Edades de 18 a 70 · Todos los sexos · Actualizado el 28 oct 2026 · NCT07226661Study of ALTO-300 in MDD
- Site 238, Fayetteville
- Site 293, Stone Mountain
ReclutandoFase 2
Edades de 18 a 70 · Todos los sexos · Actualizado el 26 oct 2026 · NCT05922878Treatment ResistAnt Depression Subcallosal CingulatE Network DBS (TRANSCEND)
- Emory University Hospital, Atlanta
Reclutando
Edades de 22 a 70 · Todos los sexos · Actualizado el 16 oct 2026 · NCT06423430A Study to Evaluate the Effectiveness of DT-101 as an Adjunctive Treatment in Patients With Depression
- Draig Clinical Site, Decatur
ReclutandoFase 2
Edades de 18 a 75 · Todos los sexos · Actualizado el 14 oct 2026 · NCT07610473Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol
- Clinical Research Site, Atlanta
- Clinical Research Site, Norcross
- Clinical Research Site, Snellville
ReclutandoFase 3
Edades de 18 a 65 · Todos los sexos · Actualizado el 13 oct 2026 · NCT07484217A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression
- Draig Clinical Site, Atlanta
- Draig Clinical Site, Decatur
ReclutandoFase 2
Edades de 18 a 75 · Todos los sexos · Actualizado el 8 oct 2026 · NCT07300969JAK Signaling in Depression
- Emory University, Atlanta
ReclutandoFase 2
Edades de 25 a 55 · Todos los sexos · Actualizado el 28 sept 2026 · NCT07003997Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive Disorder
- Vanda Investigational Site, Snellville
ReclutandoFase 3
Edades de 18 a 65 · Todos los sexos · Actualizado el 24 sept 2026 · NCT06830044A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor
- Neurocrine Clinical Site, Augusta
ReclutandoFase 4
Edades de 18 en adelante · Todos los sexos · Actualizado el 18 sept 2026 · NCT07105111Leucine in Midlife Depression
- Emory University Hospital, Atlanta
ReclutandoFase 2
Edades de 35 a 65 · Todos los sexos · Actualizado el 11 sept 2026 · NCT06580145NBI-1065845-MDD3025: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, Atlanta
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 11 ago 2026 · NCT06911112Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder
- CenExel iRS (iResearch Savannah), Savannah
ReclutandoFase 2
Edades de 18 a 64 · Todos los sexos · Actualizado el 3 ago 2026 · NCT06547489A Phase 2 Study of Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder
- Denali Health Atlanta, LLC, Stone Mountain
ReclutandoFase 2
Edades de 18 a 64 · Todos los sexos · Actualizado el 27 jul 2026 · NCT07115329A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder
- Trialmed /ID# 277601, Atlanta
- Evergreen Clinical Trials - Norcross /ID# 279421, Norcross
ReclutandoFase 2
Edades de 18 a 65 · Todos los sexos · Actualizado el 15 jun 2026 · NCT07276997Glutamatergic Adaptation to Stress as a Mechanism for Anhedonia and Treatment Response With Ketamine
- Emory University, Atlanta
ReclutandoFase 1 tempranaSe aceptan voluntarios sanos
Edades de 18 a 65 · Todos los sexos · Actualizado el 26 may 2026 · NCT05327699REVEAL Study - Diagnostic Testing for PTSD Using the Senseye Diagnostic Tool
- Savannah VA Clinic, Savannah
ReclutandoFase 3Se aceptan voluntarios sanos
Edades de 18 en adelante · Todos los sexos · Actualizado el 29 abr 2026 · NCT07280065Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services
- University of Georgia, Athens
ReclutandoEstudio observacional
Edades de 18 a 40 · Todos los sexos · Actualizado el 10 mar 2026 · NCT06740383Study of ABX-002 for the Adjunctive Treatment of Major Depressive Disorder (AMPLIFY)
- Autobahn Site #112, Decatur
- Autobahn Site #142, Peachtree Corners
ReclutandoFase 2
Edades de 18 a 65 · Todos los sexos · Actualizado el 20 ene 2026 · NCT06633016A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms
- Clinical Research Site, Atlanta
ReclutandoFase 4
Edades de 18 a 65 · Todos los sexos · Actualizado el 23 ene 2025 · NCT06223880De ClinicalTrials.gov, datos obtenidos el 15 nov 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.